These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33968297)

  • 1. Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
    Oxid Med Cell Longev; 2021; 2021():6648093. PubMed ID: 33968297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.
    Al Sharie AH; Al Masoud EB; Jadallah RK; Alzghoul SM; Darweesh RF; Al-Bataineh R; Lataifeh LN; Salameh ST; Daoud MN; Rawashdeh TH; El-Elimat T; Alali FQ
    Medicine (Baltimore); 2024 Sep; 103(39):e39678. PubMed ID: 39331921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
    Front Genet; 2020; 11():617872. PubMed ID: 33488680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
    Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
    BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma.
    Meng H; Jiang X; Huang H; Shen N; Guo C; Yu C; Yin G; Wang Y
    Cancer Med; 2021 Sep; 10(17):5823-5838. PubMed ID: 34327857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of a gene signature in clear cell renal cell carcinoma.
    Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
    J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Wu Y; Zhang X; Wei X; Feng H; Hu B; Deng Z; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
    Oxid Med Cell Longev; 2021; 2021():9939331. PubMed ID: 34868460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 13-gene risk score system and a nomogram survival model for predicting the prognosis of clear cell renal cell carcinoma.
    Zhang C; Wang F; Guo F; Ye C; Yang Y; Huang Y; Hou J; Tian F; Yang B
    Urol Oncol; 2020 Mar; 38(3):74.e1-74.e11. PubMed ID: 31952997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEK is a novel prognostic marker for clear cell renal cell carcinoma.
    Ha M; Son YR; Kim J; Park SM; Hong CM; Choi D; Kang W; Kim JH; Lee KJ; Park D; Han ME; Oh SO; Lee D; Kim YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1451-1458. PubMed ID: 30840266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
    Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
    Front Oncol; 2023; 13():1124080. PubMed ID: 36776317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.